+499.5%
MRNA vs SU
+71.8%
+427.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SU | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.7% | -1.5% | -2.4% |
| 7D | +5.5% | +3.6% | +1.9% | +6.4% |
| 30D | +158.7% | +7.9% | +150.9% | +161.3% |
| 3M | +182.1% | +3.5% | +178.6% | +193.0% |
| 6M | +151.8% | +19.0% | +132.9% | +138.2% |
| YTD | +393.6% | +55.0% | +338.6% | +314.7% |
| 1Y | +499.5% | +71.2% | +428.3% | +418.6% |
| All | +499.5% | +71.8% | +427.6% | +418.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SU.
Daily Out/Under-Performance
Portfolio return minus SU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling